Join
Live feed
·
INSIDERFilingvia Quantisnow
Silexion Therapeutics Corp logo

Chairman and CEO Hadar Ilan was granted 10,000 units of Ordinary Shares, increasing direct ownership by 153% to 16,547 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SLXN· Silexion Therapeutics Corp
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLXN (Silexion Therapeutics Corp) and more on Quantisnow.